> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Mull Clozapine REMS Potential Changes
- URL: https://www.fdaweb.com/panel-to-mull-clozapine-rems-potential-changes/
- Published: 2024-08-09T12:00:00.000Z
- Updated: 2026-09-14T14:37:51.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5157545

*Federal Register* notice: FDA is announcing an 11/19 joint meeting of its Drug Safety and Risk Management Advisory Committee and the Psychopharmacologic Drugs Advisory Committee. Panel members are scheduled to discuss a reevaluation of the clozapine risk evaluation and mitigation strategy and potential changes to reduce the burden on patients, pharmacies, and prescribers. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2024-08-09/pdf/2024-17752.pdf?ref=fdaweb.com).